Most Recent Articles by Natasha Persaud
Dialysis patients were more likely than transplant recipients to die from pre-existing cancers, whereas transplant recipients were more likely to die from de novo cancers.
Individuals taking more than 7 defined daily doses of NSAIDs each month had 20% greater risks of acute kidney injury and chronic kidney disease than those taking none.
Median metastasis-free survival was longer with darolutamide than with placebo: 40.4 vs 18.4 months.
In a "real world" study, biopsy and surgical grade groups 2, 3, 4, and 5 each were associated with incrementally higher risks for adverse pathologic features and biochemical recurrence.
Parathyroid gland volume more than halved in patients treated with cinacalcet for 8 years.
More Articles by Natasha Persaud
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)